profit from every $100 of sales.
$0$100
Alignment Healthcare
$7.69+0.26% today
-53.3% in 1 year
1-year low $7.001-year high $24.56
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Alignment Healthcare sold, what it kept, and what it did with the cash.
Sales went from $1.43 billion in 2022 to $3.95 billion in 2025, with -$724,000 of profit last year.
SalesProfit
Alignment Healthcare vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Alignment Healthcare | No profit yet | ||
 Centene | No profit yet | ||
 Clover Health Investments | No profit yet | ||
 Basel Medical Group Ltd Ordinary Shares | No profit yet | ||
 Caring Brands | No profit yet |
AI analysis
An AI analyst reads Alignment Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,434 | 1,824 | 2,704 | 3,949 | |
| 184 | 201 | 297 | 489 | |
| -129 | -128 | -102 | 15 | |
| -114 | -105 | -77 | 45 | |
| -150 | -148 | -128 | -1 | |
| -0.83 | -0.79 | -0.67 | 0.00 | |
| 12.8% | 11.0% | 11.0% | 12.4% | |
| -9.0% | -7.0% | -3.8% | 0.4% | |
| -10.4% | -8.1% | -4.7% | -0.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 634 | 592 | 782 | 1,066 |
| Cash | 410 | 203 | 433 | 576 |
| Total debt | 165 | 171 | 329 | 330 |
| Total liabilities | 395 | 434 | 681 | 887 |
| 238 | 157 | 100 | 179 | |
| 181 | 186 | 191 | 198 | |
| -25.7% | -30.6% | -19.2% | 2.3% | |
| -62.8% | -94.3% | -128.2% | -0.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -45 | -59 | 35 | 140 | |
| 24 | 36 | 41 | 27 | |
| -69 | -95 | -7 | 113 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | – | – | |
| 82 | 67 | 71 | 62 |
Valuation
- –
- 48.1×
- –
- 17.8×
- 0.4×
- 14.2×
- 30.1×
- 7.0%
- -0.0%
- 0.0%
Profitability
- 12.4%
- 0.4%
- -0.0%
- 1.6%
- 5.9%
- -30.9%
- 11.5%
- 1.6%
- 5.9%
- –
Growth
- +40.2%
- –
- +1,802.0%
- –
- +3.6%
Financial health
- -16.3×
- 1.59
- 26.2%
- 2.2×
- 1.75
- 1.75
- 3.37
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 48%of 958
Bottom 27%of 889
Top 14%of 890
Top 14%of 987
What analysts expect
- Average price target
- $25.40
- Range
- $19.00 – $30.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 0.05 | 0.01 | +400.0% |
| Feb 26, 2026 | -0.05 | -0.15 | +66.7% |
| Oct 30, 2025 | 0.02 | -0.01 | +300.0% |
| Jul 30, 2025 | 0.07 | -0.07 | +200.0% |
| May 1, 2025 | -0.05 | -0.12 | +58.3% |
| Feb 27, 2025 | -0.16 | -0.18 | +11.1% |
| Oct 29, 2024 | -0.14 | -0.14 | +0.0% |
| Aug 1, 2024 | -0.13 | -0.14 | +7.1% |
News
Alignment Healthcare downgraded at BofA after CMS Star Rating for MA contractSeeking Alpha · Oct 9, 2026RGP expects Q2 revenue of $95M-$100M as it targets utilization and cost alignmentSeeking Alpha · Oct 7, 2026OpenAI proposes development of global AI standards to guide alignment, RSICNBC · Sep 21, 2026U.S. still watching allies for alignment of interests even amid defense pullback, analyst saysCNBC · Aug 26, 2026Volato Group to merge with Alignment Engine in $500M dealSeeking Alpha · Aug 26, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
30No pass
Benjamin Graham
19No pass
Philip Fisher
37No pass
Peter Lynch
62Pass
Joel Greenblatt
1No pass
Charlie Munger
19No pass
Terry Smith
30No pass
Questions about Alignment Healthcare
Is Alignment Healthcare a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Alignment Healthcare AI analysis
What does Alignment Healthcare do?
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. It is in Medical - Healthcare Plans, based in Orange, CA, United States, with 1,849 employees.
Does Alignment Healthcare pay a dividend?
No. Alignment Healthcare does not pay a dividend at the moment.
Is Alignment Healthcare stock halal?
No. Alignment Healthcare does not pass our halal screen: its main business, conventional insurance, is not permitted. How we check
How has Alignment Healthcare stock done over the past year?
Down 53.3% over the past twelve months, to $7.69. It traded between $7.00 and $24.56 and is 68.7% below its high.
Who are Alignment Healthcare's competitors?
The largest listed companies in the same industry are Centene, Clover Health Investments, Basel Medical Group Ltd Ordinary Shares and Caring Brands. The peers table on this page compares their profit, growth and price with Alignment Healthcare's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.